Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 1, 2016
Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2016. Learn how to tune in.
-
Mar 29, 2016
Boston Scientific will participate in the healthcare conference on April 12, 2016. A live webcast and replay will be available.
-
Mar 24, 2016
Scheduled abstracts will highlight 'real-world' and clinical trial experiences with technologies developed to treat patients with a range of cardiovascular diseases
Mar 22, 2016Boston Scientific Corporation (NYSE: BSX) today announced the launch of the AXIOS™ Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious complications from...
- Mar 16, 2016
Two organizations to share intellectual property and stimulate the rapid development of medical devices to address unmet clinical needs
Mar 10, 2016FDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheterFDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheter
-
Mar 1, 2016
Boston Scientific will participate in the healthcare conference on March 15, 2016. Learn how to watch the webcast or replay.
-
Feb 25, 2016Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman
Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman
-
Feb 23, 2016
Boston Scientific will participate in the healthcare conference on March 8, 2016. Learn how to watch the webcast or replay.
Feb 23, 2016FDA-Approved ACUITY™ X4 Quadripolar Left Ventricular Leads to be used in Trial Pursuing MRI Labeling for Cardiac Defibrillation and Resynchronization SystemsACUITY™ X4 Quadripolar Left Ventricular Leads to be used in trial pursuing MRI labeling for cardiac defibrillation and resynchronization systems
Feb 22, 2016First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe; IMPERIAL trial initiated to seek regulatory approvals in U.S. and AsiaFirst polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe
-
Feb 8, 2016CMS will cover percutaneous LAAC therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met
CMS will cover percutaneous LAAC therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met
- Feb 4, 2016
"Our accomplishments in 2015 demonstrate our continued momentum,” said Boston Scientific CEO Mike Mahoney
Feb 1, 2016Boston Scientific Bronchial Thermoplasty (BT) Delivered by the ALAIR™ System Offers Proven Reduction in Asthma Attacks for Adult Patients with Severe Asthma Not Well Controlled with MedicationBronchial thermoplasty (BT) delivered by the ALAIR™ System offers proven reduction in asthma attacks for adults with severe asthma not well controlled with medication
Jan 28, 2016Care Pathway Transformation solution is designed to enable providers to make better-informed decisions based on patient population insightsCare Pathway Transformation solution is designed to enable providers to make better-informed decisions based on patient population insights
- Jan 27, 2016
Boston Scientific will participate in the healthcare conference on February 10, 2016. Learn how to watch the webcast or replay.
Jan 12, 2016Boston Scientific Launches The LithoVue™ Single-Use Digital Flexible Ureteroscope In U.S. And EuropeSingle-Use System for Stone Removal Eliminates Maintenance, Reprocessing and SterilizationSingle-use system for stone removal eliminates maintenance, reprocessing and sterilization
Jan 4, 2016Boston Scientific will webcast its conference call discussing financial results and business highlights for Q4 ended December 31, 2015
